The prevention of colorectal cancer by aspirin use

Biomedicine and Pharmacotherapy

Volumn 53, Issue 7, 1999, Pages 303-308

  Giovannucci, E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Aspirin; Chemoprevention; Colonic neoplasm; Colorectal neoplasm; NSAIDs

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SULINDAC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; BLEEDING; CANCER PREVENTION; CANCER RISK; COLON CARCINOGENESIS; COLORECTAL CANCER; DRUG EFFICACY; ENZYME INHIBITION; GASTROINTESTINAL SYMPTOM; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033178020     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(00)88500-5     Document Type: Article

References (53)

1. Barnes CJ, Lee M. Chemo-prevention of spontaneous intestinal adenomas the adenomatous polyposis coli Min mouse model with aspirin. Gastroenterology 1998; 114 : 873-7.
2. Bomalaski JS, Hirata F, Clark MA. Aspirin inhibits phospholipase C. Biochem Biophys Res Commun 1986; 139 : 115-21.
3. Craven PA, DeRubertis FR. Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis. Carcinogenesis 1992; 13 : 541-6.
4. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LBA, et al. Cyclooxygenase in biology and disease. FASEB J 1998; 12 : 1063-73.
5. Freedman AN, Michalek AM, Weiss HA, Zhang ZF, Marshall JR, Mettlin CJ, et al. Aspirin use and p53 expression in colorectal cancer. Cancer Detect Prev 1998; 22 : 213-8.
6. Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 1993; 85 : 1220-4.
7. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 328 : 1313-6.
8. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995; 333 : 609-14.
9. Giovannucci E, Rimm EB, Stamofer MJ. Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994; 121 : 241-6.
10. Gonzaga RA, Lima FR, Cameiro S, Amarante J. Sulindac treatment for familial polvposis coli. Lancet 1985; 1 : 751.
11. Greehberg ER, Baron JA, Freeman DH, Mandel JS, Haile R, the Polyp Prevention Study Group. Reduced risk of large-bowel adenomas among aspirin users. J Nat Cancer Inst 1993; 85 : 912-6.
12. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, et al. Incidence of cancer among patients with rheumatoid arthritis. J Nat Cancer Inst 1993; 85 : 307-11.
13. Herzog PKH, Holtermüller J, Preiss J, Fischer K, Ewe HJ, Schreiber M, et al. Fecal blood loss in patients with colonic polyps, a comparison of measurements with 51-chromium-labelled erythrocytes and with the Haemoccult test. Gastroenterology 1982; 83 : 957-62.
14. Isomaki HA, Hakufinen T, Joutsenlahtl U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis 1978; 31 : 691-6.
15. Jen J, Powell SM, Papadopoulos N, Smith KA, Hamilton SR, Vogelstein B, et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994; 54 : 5523-6.
16. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne colorectal cancer study. Cancer Res 1988; 48 : 4399-404.
17. La Vecchia C, Negri E, Franceschi S, Conti E, Montella M, Giacosa A, Aspirin and colorectal cancer. Br J Cancer 1997; 76 : 675-7.
18. Laakso M, Mutru O, Isomaki H, Koota K. Cancer mortality in patients with rheumatoid arthritis. J Rheumatol 1986; 13 : 522-56.
19. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991; 101 : 635-9.
20. Logan RF, Little J, Hawtin PG, Hardcastie JD. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: Case-control study of subjects participating in the Nottingham fecal occult blood screening program. Br Med J 1993; 307 : 285-9.
21. Macrae FA, St John DJB. Relationship between patterns of bleeding and hemeoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982; 82 : 891-8.
22. Marnett LJ. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 1992; 52 : 5575-89.
23. Martinez ME, McPherson RS, Levin B, Annegers JF. Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals. Cancer Epidemiol Biomarkers Prev 1995; 4 : 703-7.
24. Matsuhashi N, Nakajima A, Fukushima Y, Yazaki Y, Oka T. Effects of sulindac on sporadic colorectal adenomatous polyps. Gut 1997; 40 : 344-9.
25. Mereto E, Frencia L, Ghia M. Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine. Cancer Lett 1994; 76 : 5-9.
26. Moorghen M, Ince P, Finney KJ, Sunter JP, Appleton DR, Watson AJ. A protective effect of sulindac against chemically-induced primary colonic tumors in mice. J Pathol 1988; 156 : 341-7.
27. Muller AD, Sonnenberg A, Wasserman IH. Diseases preceding colon cancer. A case-control study among veterans. Dig Dis Sci 1994; 39 : 2480-4.
28. Muscat JE, Stellman SD, Wynder EL. Non-steroidal anti-inflammatory drugs and colorectal cancer. Cancer 1994; 74 : 1847-54.
29. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36 : 2251-70.
30. Narisawa T, Sato M, Tani M, Kudo T, Takahashi T, Goto A. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res 1981; 41 : 1954-7.
31. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, et al. Suppression of intestinal polyposis in Apc716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell 1996; 87 : 803-9.
32. Paganini-Hill A, Chao A, Ross R, Henderson B. Aspirin use and chronic diseases: A cohort study of the elderly. Br Med J 1989; 299 : 1247-50.
33. Peleg LL, Maibach HT, Brown SH, Wilcox CM. Aspirin and non-steroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer, Arch Intern Med 1994; 154 : 394-9.
34. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO. Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study. Gastroenterology 1994; 107 : 117-20.
35. Pollard M, Luckert PH. Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. Cancer Treat Rep 1980; 64 : 1323-7.
36. Pollard M, Luckert PH. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science 1981; 214 : 558-9.
37. Pollard M, Luckert PH. Treatment of chemically-induced intestinal cancers with indomethacin. Proc Soc Exp Biol Med 1981; 167 : 161-4.
38. Pollard M, Luckert PH, Schmidt MA. The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat. Cancer Lett 1983; 21: 57-61.
39. Powis G, Alberts DS. Inhibiting intracellular signaling as a strategy for cancer chemo-prevention. Eur J Cancer 1994; 30A: 1138-44.
40. Reddy BS, Maruyama H, Kelloff G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a non-steroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Res 1987; 47 : 5340-6.
41. Reddy BS, Rao CV, Rivenson A, Kelloff G. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 1993; 14 : 1493-7.
42. Rigau J, Pique JM, Rubio E, Planas R, Tarrech JM, Bordas JM. Effects of long-term sulindac therapy on colonic polyposis. Ann Intern Med 1991; 115 : 952-4.
43. Rosenberg L, Palmer J, Zauber A, Warshauer M, Stolley P, Shapiro S. A hypothesis: Non-steroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 1991; 83 : 355-8.
44. Schreinemachers D, Everson R. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994; 5 : 138-46.
45. Steering committee of the Physicians' Health Study research group. Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med 1989; 321 : 129-35.
46. Stürmer T, Glynn RJ, Lee IM, Manson JE, Buring JE, Hennekens CH. Aspirin use and colorectal cancer: Post-trial follow-up data from the physicians' health study. Ann Intern Med 1998; 128 : 713-20.
47. Suh O, Mettlin C, Petrelli NJ. Aspirin use, cancer, and polyps of the large bowel. Cancer 1993; 72 : 1171-7.
48. Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis. J Natl Cancer Inst 1998; 90 : 1609-20.
49. Thun M, Namboodiri M, Calle E, Flanders W, Heath CJ. Aspirin use and risk of fatal cancer. Cancer Res 1993; 53 : 1322-7.
50. Thun MJ, Namboodiri MM, Heath CJ. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991; 325 : 1593-6.
51. Trujillo MA, Garewal HS, Sampliner RE. Non-steroidal anti-inflammatory agents in chemo-prevention of colorectal cancer. At what cost? Dig Dis Sci 1994; 39 : 2260-6.
52. Waddell WR, Ganser GF, Cerise EJ, Loughry RW. Sulindac for polyposis of the colon. Am J Surg 1989; 157 : 175-9.
53. Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol 1983; 24 : 83-7.